What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Innovent Biologics begins parsaclisib phase 2 trial in follicular lymphoma Innovent Biologics has dosed the first patient in a phase 2 trial of parsaclisib (IBI-376), a novel and… bypharmanewsdailyApril 28, 2020
